N. D. Eyüpoğlu et al., “Event-free Survival in Patients with Chronic Myeloid Leukemia Receiving Front-line Imatinib Mesylate”, Acta Medica, vol. 53, no. 3, pp. 277–283, Jun. 2022, doi: 10.32552/2022.ActaMedica.745.